Henrik Bergentoft Insider Profile
4 Followers
Henrik Bergentoft, Chief Financial Officer at Oncopeptides AB, holds 42.77K shares in Oncopeptides AB (Ticker: SE:ONCO). Most recently, Henrik Bergentoft Bought 14,258 shares of Oncopeptides AB on Mar 17, 2026 for an estimated value of kr22.10K.
Henrik Bergentoft's Trading History
| ONCOOncopeptides AB | Mar 17, 2026 | Chief Financial Officer | Informative Buy | 22.10K | kr75.28K | ||||||||||||||||||||||||||||||||||||
SE:ONCO Insider Shares: 42.77K (1.10%)
| |||||||||||||||||||||||||||||||||||||||||
You May Also Like
Henrik Bergentoft insider profile FAQ
What is the percentage of profitable transactions made by Henrik Bergentoft?
The percentage of profitable transactions made by Henrik Bergentoft is 25%.
What is the average return per transaction made by Henrik Bergentoft?
The average return per transaction made by Henrik Bergentoft is -41.60%.
What stocks does Henrik Bergentoft hold?
Henrik Bergentoft holds: SE:ONCO stocks.
What was Henrik Bergentoft’s latest transaction?
Henrik Bergentoft’s latest transaction was an Informative Buy of kr22.10K.
What was Henrik Bergentoft's most profitable transaction?
Henrik Bergentoft’s most profitable transaction was an Informative Buy of SE:ONCO stock on March 17, 2026. The return on the trade was 3.00%.
What is Henrik Bergentoft's role in Oncopeptides AB?
Henrik Bergentoft's role in Oncopeptides AB is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.